ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 265 filers reported holding ROYALTY PHARMA PLC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,741,639 | -11.9% | 248,402 | -0.3% | 0.30% | -7.8% |
| Q2 2023 | $7,655,380 | +4.7% | 249,036 | +22.7% | 0.32% | -2.7% |
| Q1 2023 | $7,312,722 | +74.7% | 202,962 | +91.6% | 0.33% | +67.0% |
| Q4 2022 | $4,186,630 | -1.7% | 105,937 | -0.0% | 0.20% | -11.3% |
| Q3 2022 | $4,258,000 | -4.4% | 105,953 | +0.0% | 0.22% | -4.3% |
| Q2 2022 | $4,454,000 | -3.6% | 105,937 | -10.6% | 0.23% | +23.4% |
| Q1 2022 | $4,619,000 | +36.9% | 118,556 | +40.0% | 0.19% | +39.3% |
| Q4 2021 | $3,375,000 | – | 84,704 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $244,378,000 | 79.54% |
| Vantage Consulting Group Inc | 7,862,542 | $284,152,000 | 60.85% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $96,878,000 | 60.36% |
| Indie Asset Partners, LLC | 701,323 | $25,346,000 | 20.53% |
| HARVARD MANAGEMENT CO INC | 7,142,856 | $258,143,000 | 15.13% |
| Bleichroeder LP | 1,115,980 | $40,332,000 | 6.55% |
| Overbrook Management Corp | 785,132 | $28,375,000 | 6.16% |
| Geo Capital Gestora de Recursos Ltd | 194,305 | $7,022,000 | 3.21% |
| Brown University | 621,759 | $22,470,000 | 3.05% |
| Graypoint LLC | 610,584 | $22,067,000 | 2.71% |